Compare Toronto-Dominion Bank (TD) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Toronto-Dominion Bank vs GeneDx Holdings Corp — how do they compare? Toronto-Dominion Bank trades at $123.07 (market cap $200.48B), while GeneDx Holdings Corp trades at $82.15 (market cap $2.44B). The key difference: Toronto-Dominion Bank is far larger — about 82.2× GeneDx Holdings Corp's market cap, and Toronto-Dominion Bank pays a 2.63% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| TD | WGS | |
|---|---|---|
Market Cap | $200.48B | $2.44B |
Sector | Financials | Technology |
52-Week High | $124.80 | $167.51 |
52-Week Low | $72.85 | $34.51 |
Dividend Yield | 2.63% | — |
Enterprise Value | — | $2.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TD trades at $121.08, down 0.19% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS expected at $1.70. Revenue grew to $61.28 billion in 2025, and net income margin improved to 33.51%. A dividend of $1.12 is scheduled for payment on July 31, 2026.
The outlook is positive given consistent earnings outperformance and a solid dividend, but risks include high debt levels and volatile cash flows. Analyst consensus is bullish with no sell ratings, supporting a favorable medium-term view amid macroeconomic uncertainties.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
